CytoMed Therapeutics Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	6.47	9	1.58	2.51	0.89	0.37
Short-Term Investments	0.35	-	-	0.02	0.04	0.08
Cash & Short-Term Investments	6.82	9	1.58	2.53	0.93	0.45
Cash Growth	-34.63%	469.41%	-37.51%	172.19%	104.15%	-
Other Receivables	0.05	0.2	0.06	0.01	0.01	0
Receivables	0.05	0.2	0.06	0.01	0.01	0
Inventory	0.72	0.68	0.58	0.43	0.24	0.05
Prepaid Expenses	0.12	0.16	0.05	0.14	0.04	0.04
Other Current Assets	-	0.06	0.24	0.18	0.25	-
Total Current Assets	7.71	10.1	2.49	3.28	1.47	0.54
Property, Plant & Equipment	2.48	2.06	2.47	2.5	2.3	2.34
Long-Term Investments	0.21	0.2	0.24	0.27	-	-
Goodwill	0	0	0	0	0	0
Other Intangible Assets	0.01	0.01	0.02	0.03	0.04	0.04
Total Assets	10.91	12.37	5.23	6.08	3.82	2.92
Accounts Payable	0.04	0.02	0.01	0.05	0.02	0.01
Accrued Expenses	0.24	0.45	0.24	0.15	0.29	0.03
Short-Term Debt	-	-	3.7	2.66	2.32	-
Current Portion of Long-Term Debt	0.03	0.03	0.03	0.04	0.04	0.04
Current Portion of Leases	0	0.01	0.01	0.01	0.01	0.01
Current Income Taxes Payable	-	-	0	-	-	-
Current Unearned Revenue	0.01	0.01	0.01	0.02	0.02	-
Other Current Liabilities	0.02	0.2	0.16	0.02	0.04	0.28
Total Current Liabilities	0.36	0.72	4.17	2.94	2.73	0.37
Long-Term Debt	0.39	0.41	0.47	0.54	0.59	0.6
Long-Term Leases	-	-	0.01	0.02	0.02	0.03
Total Liabilities	0.75	1.12	4.64	3.49	3.34	1
Common Stock	23.79	23.72	8.91	6.55	3.5	3
Retained Earnings	-13.42	-12.33	-8.2	-5.07	-3.02	-1.08
Comprehensive Income & Other	-0.21	-0.14	-0.13	1.11	-0.01	-0
Total Common Equity	10.16	11.25	0.59	2.59	0.48	1.92
Minority Interest	-0	-0	-0	-0	-0	-
Shareholders' Equity	10.16	11.24	0.59	2.59	0.48	1.92
Total Liabilities & Equity	10.91	12.37	5.23	6.08	3.82	2.92
Total Debt	0.43	0.45	4.22	3.26	2.98	0.67
Net Cash (Debt)	6.39	8.55	-2.64	-0.73	-2.05	-0.21
Net Cash Per Share	0.55	0.80	-0.33	-0.11	-0.35	-0.04
Filing Date Shares Outstanding	11.54	11.54	11.53	8.44	6.08	5.55
Total Common Shares Outstanding	11.54	11.53	8.44	7.48	6.08	5.55
Working Capital	7.35	9.38	-1.67	0.35	-1.26	0.17
Book Value Per Share	0.88	0.98	0.07	0.35	0.08	0.35
Tangible Book Value	10.15	11.23	0.57	2.56	0.43	1.88
Tangible Book Value Per Share	0.88	0.97	0.07	0.34	0.07	0.34
Land	-	0.37	0.39	0.42	0.43	0.43
Buildings	-	1.06	1.1	1.13	0.65	0.65
Machinery	-	1.54	1.57	1.27	1.31	1.08

Source: S&P Capital IQ. Standard template. Financial Sources.